Apr 30, 2025
Story at-a-glance
- FDA failed to prioritize over 70,000 adverse event reports related to puberty-blocking drugs, raising concerns about regulatory oversight of these medications
- Side effects from puberty blockers range from headaches to serious conditions like brain swelling and vision loss
- Puberty blockers disrupt normal development, causing long-term harm to physical development and psychological health in children
- The FDA's handling of puberty blockers demonstrates inconsistent regulatory standards and inadequate public warnings about significant risks
- The safety of puberty blockers and other gender-affirming care has not been established, and parents should research risks before making decisions